PL2730279T3 - Preparaty cynakalcetu o natychmiastowym uwalnianiu - Google Patents

Preparaty cynakalcetu o natychmiastowym uwalnianiu

Info

Publication number: PL2730279T3
Authority: PL; Poland
Prior art keywords: cinacalcet; immediate release; release formulations; formulations; immediate
Prior art date: 2012-11-09

Application number

PL12007638T

Other languages

English (en)

Inventor

Silva Gabriel Leitão

Stephanie Cadonau

Simões Sérgio Paulo

Christian Drescher

Original Assignee

K H S Pharma Holding Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-11-09

Filing date

2012-11-09

Publication date

2015-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47189684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2730279(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-11-09 Application filed by K H S Pharma Holding Gmbh filed Critical K H S Pharma Holding Gmbh

2015-12-31 Publication of PL2730279T3 publication Critical patent/PL2730279T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Medicinal Preparation (AREA)

PL12007638T 2012-11-09 2012-11-09 Preparaty cynakalcetu o natychmiastowym uwalnianiu PL2730279T3 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP12007638.5A EP2730279B1 (en)	2012-11-09	2012-11-09	Immediate release formulations of cinacalcet

Publications (1)

Publication Number	Publication Date
PL2730279T3 true PL2730279T3 (pl)	2015-12-31

Family

ID=47189684

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL12007638T PL2730279T3 (pl)	2012-11-09	2012-11-09	Preparaty cynakalcetu o natychmiastowym uwalnianiu

Country Status (6)

Country	Link
US (1)	US20150306049A1 (pl)
EP (1)	EP2730279B1 (pl)
DK (1)	DK2730279T3 (pl)
ES (1)	ES2547577T3 (pl)
PL (1)	PL2730279T3 (pl)
WO (1)	WO2014072346A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20210030671A1 (en)	2018-03-30	2021-02-04	Ftf Pharma Private Limited	Liquid dosage forms of cinacalcet or salt thereof
CN112546010A (zh) *	2020-12-02	2021-03-26	普莱赛思(天津)生命科技有限公司	一种肾病药物组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE359259T1 (de)	1994-10-21	2007-05-15	Nps Pharma Inc	Kalzium-rezeptor aktive verbindungen
CA2536487C (en)	2003-09-12	2011-10-25	Amgen Inc.	Rapid dissolution formulation of a calcium receptor-active compound
US7563930B2 (en)	2005-11-22	2009-07-21	Teva Pharmaceutical Industries Ltd	Crystal forms of Cinacalcet HCI and processes for their preparation
CA2662315A1 (en)	2006-09-01	2008-03-06	Teva Pharmaceutical Industries Ltd.	Solid composites of a calcium receptor-active compound
WO2008064202A2 (en)	2006-11-20	2008-05-29	Dr. Reddy's Labortories, Ltd.	Modified-release formulations of calcium receptor-active compounds
EP2300415A2 (en)	2008-05-05	2011-03-30	Medichem, S.A.	Process for controlling the particle size of a 3-(trifluoromethyl)phenyl¨-1-aminopropane derivative
ES2393067T3 (es)	2008-09-25	2012-12-18	Ratiopharm Gmbh	Cinacalcet compactado
CA2818565A1 (en)	2010-11-23	2012-05-31	Amgen Inc.	Pediatric formulation

2012
- 2012-11-09 DK DK12007638.5T patent/DK2730279T3/en active
- 2012-11-09 EP EP12007638.5A patent/EP2730279B1/en not_active Revoked
- 2012-11-09 ES ES12007638.5T patent/ES2547577T3/es active Active
- 2012-11-09 PL PL12007638T patent/PL2730279T3/pl unknown
2013
- 2013-11-06 WO PCT/EP2013/073173 patent/WO2014072346A1/en not_active Ceased
- 2013-11-06 US US14/441,223 patent/US20150306049A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20150306049A1 (en)	2015-10-29
ES2547577T3 (es)	2015-10-07
DK2730279T3 (en)	2015-10-26
WO2014072346A1 (en)	2014-05-15
EP2730279B1 (en)	2015-07-22
EP2730279A1 (en)	2014-05-14

Publication	Publication Date	Title
ZA201501847B (en)	2016-01-27	Formulations of enzalutamide
IL234256B (en)	2020-08-31	Tamper resistant immediate release formulations
IL236304A0 (en)	2015-02-26	Formulations for diclofenac
ZA201503603B (en)	2016-01-27	Composition for immediate and extended release
HUE064884T2 (hu)	2024-04-28	Bendamusztin kiszerelések
EP4342536C0 (en)	2025-10-01	BROMOCRIPTINE FORMULATIONS
PL2833884T3 (pl)	2020-11-02	Zastosowanie inhibitorów ccr3
ZA201409259B (en)	2016-07-27	Insecticidal formulations of microcapsules
AP3681A (en)	2016-04-19	Modified release formulations for oprozomib
LT2729130T (lt)	2018-01-10	Darunaviro derinių kompozicijos
SI2753311T1 (sl)	2020-12-31	Formulacije antioksidanta
GB201501016D0 (en)	2015-03-04	Preparation of 18F-fluciclovine
SI2623096T1 (sl)	2019-06-28	Farmacevtski sestavek s podaljšanim sproščanjem trimetazidina
ZA201308316B (en)	2014-07-30	Sustained release paracetamol formulations
EP2867199A4 (en)	2015-12-02	STABLE COMPOSITIONS OF ESOTRERODINE
GB201210530D0 (en)	2012-07-25	Extended release formulations
PL2730279T3 (pl)	2015-12-31	Preparaty cynakalcetu o natychmiastowym uwalnianiu
SG11201404915SA (en)	2014-10-30	Sustained release oral solid preparation
GB201206178D0 (en)	2012-05-23	Formulations